Seraphim Schwab

The Psychedelic Therapist ®

Seraphim Schwab

  • Psychedelic Therapy: Exposing the grifters and exploiters

Psychedelic Therapy: Exposing the grifters and exploiters

Tuesday 3rd January 2023

Seraphim Schwab exposes the greed in psychedelic therapy and advocates for accessible healing in 'The Psychedelic Therapist'.
36 minutes
Informative
Thought-provoking
Raw
Engaging
Empowering

About this podcast

The Psychedelic Therapist ®
Author:
Seraphim Schwab
Overview:
Categories:
Innovative Treatments & Recovery Paths
Healing from Sexual Trauma
Innovative Healing Arts
Mindful Recovery
Empowering Recovery Journeys
Links:
Visit site
Episodes:
6 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Psychedelic Therapy: Battling Greed and Opening Doors to Healing

Until I see actual access happening for people, realistically to me it's just about greed and elitism and everyone patting each other on the back while they're trying to get their patents and their research, and they really don't care.
Feeling frustrated by the high costs and exclusivity of psychedelic therapy? In this episode of 'The Psychedelic Therapist', Seraphim Schwab pulls back the curtain on the greed and elitism that plague the industry. Schwab, a Navy veteran who found healing through plant medicine, passionately argues for making these therapies accessible to everyone, not just the wealthy.
She dives into the eye-watering fees—$10,000 a year for a licensed facility in Oregon, $700 tickets for conferences, and underground services costing up to $3,000. It's enough to make your head spin! Schwab doesn't just rant; she offers solutions and dreams of a future where a psychedelic treatment and research center in Colorado could provide affordable care. She also encourages medical professionals to experience these therapies firsthand to better understand their patients' needs.
This episode is a compelling call to action for more equitable access to psychedelic therapy. If you're curious about the potential of plant medicine or concerned about the barriers to treatment, this conversation is a must-listen.